# Diabetes In Relation to Hospitalized COVID-19 Patents At Assiut University Hospital

> **NCT05083013** · — · UNKNOWN · sponsor: **Assiut University** · enrollment: 160 (estimated)

## Conditions studied

- Diabetes Mellitus
- COVID-19

## Interventions

- **DIAGNOSTIC_TEST:** Reverse transcription polymerase chain reaction (RT-PCR)
- **DIAGNOSTIC_TEST:** Glycated haemoglobin (HbA1C)
- **RADIATION:** High Resolution Computed Tomography (HRCT)
- **DIAGNOSTIC_TEST:** Routine Laboratory investigations
- **DIAGNOSTIC_TEST:** Random Blood Sugar (RBS)

## Key facts

- **NCT ID:** NCT05083013
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-01
- **Primary completion:** 2022-10-01
- **Final completion:** 2022-12-31
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2021-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05083013

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05083013, "Diabetes In Relation to Hospitalized COVID-19 Patents At Assiut University Hospital". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05083013. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*